Literature DB >> 33925097

Effect of Retinohypothalamic Tract Dysfunction on Melatonin Level in Patients with Chronic Disorders of Consciousness.

Mikhail Kanarskii1, Julia Nekrasova1, Svetlana Vitkovskaya1, Pranil Pradhan1, Sergey Peshkov1, Elena Borisova1, Ilya Borisov1, Olga Panasenkova1, Marina V Petrova1,2, Igor Pryanikov1.   

Abstract

OBJECTIVE: The aim of this study is to compare the secretion level of nocturnal melatonin and the characteristics of the peripheral part of the visual analyzer in patients with chronic disorders of consciousness (DOC).
MATERIALS AND METHODS: We studied the level of melatonin in 22 patients with chronic DOC and in 11 healthy volunteers. The fundus condition was assessed using the ophthalmoscopic method.
RESULTS: The average level of nocturnal melatonin in patients with DOC differed by 80% from the level of indole in healthy volunteers. This reveals a direct relationship between etiology, the level of consciousness, gaze fixation, coma recovery scale-revised score and the level of melatonin secretion. Examination by an ophthalmologist revealed a decrease in the macular reflex in a significant number of DOC patients, which in turn correlates negatively with the time from brain injury and positively with low values of nocturnal melatonin.

Entities:  

Keywords:  anoxia; chronic disorder of consciousness; melatonin; ophthalmology; retinohypothalamic tract; traumatic brain injury

Year:  2021        PMID: 33925097     DOI: 10.3390/brainsci11050559

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  19 in total

1.  Sleep cycle in patients in a state of permanent unconsciousness.

Authors:  Mitsuo Isono; Yukihiro Wakabayashi; Minoru Fujiki M; Tohru Kamida; Hidenori Kobayashi
Journal:  Brain Inj       Date:  2002-08       Impact factor: 2.311

Review 2.  Vegetative state.

Authors:  Ben-Zion Krimchansky; Tatiana Galperin; Zeev Groswasser
Journal:  Isr Med Assoc J       Date:  2006-11       Impact factor: 0.892

3.  Circadian blood pressure in patients in a persistent vegetative state.

Authors:  Y Fukudome; I Abe; Y Saku; K Matsumura; S Sadoshima; H Utunomiya; M Fujishima
Journal:  Am J Physiol       Date:  1996-05

4.  Night sleep in patients with vegetative state.

Authors:  Yuri G Pavlov; Steffen Gais; Friedemann Müller; Monika Schönauer; Barbara Schäpers; Jan Born; Boris Kotchoubey
Journal:  J Sleep Res       Date:  2017-04-26       Impact factor: 3.981

5.  Placebo-controlled trial of amantadine for severe traumatic brain injury.

Authors:  Joseph T Giacino; John Whyte; Emilia Bagiella; Kathleen Kalmar; Nancy Childs; Allen Khademi; Bernd Eifert; David Long; Douglas I Katz; Sooja Cho; Stuart A Yablon; Marianne Luther; Flora M Hammond; Annette Nordenbo; Paul Novak; Walt Mercer; Petra Maurer-Karattup; Mark Sherer
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

Review 6.  MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.

Authors:  Jiabei Liu; Shannon J Clough; Anthony J Hutchinson; Ekue B Adamah-Biassi; Marina Popovska-Gorevski; Margarita L Dubocovich
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

7.  [Sleep in vegetative state patients and recuperated cases from vegetative states (author's transl)].

Authors:  N Oka; N Kodama; J Suzuki
Journal:  No Shinkei Geka       Date:  1982-02-10

8.  Nocturnal melatonin regulation in post-traumatic vegetative state: a possible role for melatonin supplementation?

Authors:  Pietro Guaraldi; Elisa Sancisi; Chiara La Morgia; Giovanna Calandra-Buonaura; Valerio Carelli; Olivia Cameli; Alberto Battistini; Pietro Cortelli; Roberto Piperno
Journal:  Chronobiol Int       Date:  2014-03-28       Impact factor: 2.877

9.  Human Computer Interface for Tracking Eye Movements Improves Assessment and Diagnosis of Patients With Acquired Brain Injuries.

Authors:  Michał Lech; Michał T Kucewicz; Andrzej Czyżewski
Journal:  Front Neurol       Date:  2019-01-23       Impact factor: 4.003

10.  Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease.

Authors:  Angela J Oh; Giulia Amore; William Sultan; Samuel Asanad; Jason C Park; Martina Romagnoli; Chiara La Morgia; Rustum Karanjia; Michael G Harrington; Alfredo A Sadun
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.